OPPM
ICPT
Opus Point Partners Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $261K | Sell |
3,926
-1,946
| -33% | -$129K | 0.47% | 46 |
|
|
2019
Q2 | $467K | Buy |
5,872
+116
| +2% | +$9.23K | 0.69% | 36 |
|
|
2019
Q1 | $644K | Buy |
5,756
+2,222
| +63% | +$249K | 0.87% | 24 |
|
|
2018
Q4 | $356K | Sell |
3,534
-464
| -12% | -$46.7K | 0.78% | 20 |
|
|
2018
Q3 | $505K | Hold |
3,998
| – | – | 1.21% | 25 |
|
|
2018
Q2 | $335K | Sell |
3,998
-498
| -11% | -$41.7K | 0.73% | 33 |
|
|
2018
Q1 | $277K | Buy |
4,496
+717
| +19% | +$44.2K | 0.54% | 41 |
|
|
2017
Q4 | $221K | Sell |
3,779
-702
| -16% | -$41.1K | 0.19% | 52 |
|
|
2017
Q3 | $260K | Buy |
4,481
+2,661
| +146% | +$154K | 0.23% | 52 |
|
|
2017
Q2 | $220K | Sell |
1,820
-1,492
| -45% | -$180K | 0.2% | 55 |
|
|
2017
Q1 | $375K | Buy |
3,312
+1,177
| +55% | +$133K | 0.28% | 55 |
|
|
2016
Q4 | $232K | Buy |
2,135
+829
| +63% | +$90.1K | 0.18% | 52 |
|
|
2016
Q3 | $215K | Buy |
+1,306
| New | +$215K | 0.12% | 39 |
|